Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Short term Debt (2020 - 2024)

Cumberland Pharmaceuticals (CPIX) has disclosed Short term Debt for 4 consecutive years, with $5.1 million as the latest value for Q4 2024.

  • Quarterly Short term Debt changed N/A to $5.1 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $5.1 million through Dec 2024, changed N/A year-over-year, with the annual reading at $5.1 million for FY2024, N/A changed from the prior year.
  • Short term Debt hit $5.1 million in Q4 2024 for Cumberland Pharmaceuticals, down from $6.0 million in the prior quarter.
  • In the past five years, Short term Debt ranged from a high of $6.0 million in Q3 2024 to a low of $2.0 million in Q3 2020.